'1982 Vickers Award Lecture given in Cambridge on 28November 1982. (Fig. 3 ). This arises from the leakage of proteins from the capillary bed into the various tissue spaces from which they percolate to the lymphatics and return to the venous side of the circulation via the thoracic duct. For many proteins the total amount of protein in the tissue spaces, the lymphatic circulation etc. roughly equals, or is greater than, the total amount in the plasma. Based on this expanded concept it is obvious that a list of the factors determining the concentration of a plasma protein should include:
(1) the distribution and amount of body fluid;
(2) capillary permeability;
(3) lymphatic return; (4) losses in various disease states e.g. haemorrhage, protein-losing enteropathy, nephrosis, bums;
(5) synthesis of the protein, which is dependent on the availability of amino acids, energy, and endocrine environment; and (6) catabolism of the protein, which is probably mainly influenced by various hormones.
The increasing availability of computers makes it easy to explore the quantitative aspects of the metabolism and distribution of the plasma proteins. Use of a simple mathematical model adapted for a computer can illustrate clearly the interaction of the various factors which affect the concentration of specific proteins in plasma.
Much of the mathematics of this approach is shared by pharmacokinetics, some comprehension of which is obviously necessary if clinical 80 20 40 60 Among early observations on factors which influence the concentration of plasma proteins were those by Bohme on posture.' He showed that the concentration of plasma proteins in venous blood fell by about 12% in 30 minutes after an individual lay down to rest who had previously been standing erect or moving about (Fig. 1) . The aim of a computer model of plasma proteins is to explore the factors determining the concentration of proteins in plasma and the conclusions which may be drawn from observed changes in concentration.
It is generally appreciated that concentration in a compartment or pool in the body, such as the blood, can be influenced by the inflow of the substance, the outflow (as in renal excretion), and also by changes in the volume of the compartment (Fig. 2) .
Many seem to think of the plasma proteins as being confined to the plasma. This is certainly not the case except for very large molecularweight proteins, such as u2-macroglobulin, and IgM. For all other proteins there is a second biochemists are to make a contribution to therapeutic drug monitoring. Many of the mathematical solutions to the problems of interpreting data obtained from studies of plasma protein metabolism are well established.v ? Perhaps the earliest detailed discussion of the mathematical solutions for the compartmental analysis approach to the study of plasma protein metabolism is that by Matthews." Comparison of these texts with that, for example, by Gibaldi and Perrier' on pharmacokinetics clearly shows much common ground.
The first study of human plasma protein metabolism and distribution using albumin, suitably trace-labelled with radioactive iodide (131 I) was reported by Sterling in 1951. 6 The experimental procedure has been widely used since and requires a preparation of pure, undenatured protein, a gentle method of iodination such as the iodine monochloride method of Mcfarlane," and the 'blocking' of thyroid and salivary gland uptake of the radioactive iodide released by catabolism of the protein by the administration of potassium iodide during the study.
A. Simple model
The simplest two-compartment model applicable to the interpretation of such studies is shown in Fig. 4 . In this P represents the amount of the labelled protein, for example albumin, circulating in the plasma. This is in exchange with the extravascular pool of the protein (E) by the processes of capillary permeability (k 1 ) and lymphatic return (k 2 ) . Since the model is to be applied to the interpretation of the decay of radio-iodinated protein from plasma, there is no synthesis. Catabolism is represented by k c . The rates of exchange and catabolism (i.e. kJ, k 2 , and k c ) are fractional rates. Thus k c represents the fractional catabolic rate (FCR) of albumin, that is the fraction of the intravascular pool which is catabolised per day. Two differential equations describing the rate of change of the radioactive protein in the two compartments can now be written. These are: constants of exchange between the plasma and extravascular compartments and by the fractional catabolic rate.
There are several methods for solving these differential equations, all of which arrive at the same general solutions (see appendix 1).
It can be shown (see appendix 1) that the intercepts (i.e. AI. A 2 and C) and the exponents (i.e. b, and b 2 are determined by simple functions of the rate constants kI. k 2 and k.. It follows that the rate constants of exchange between compartments and catabolism determine the behaviour of the radio-labelled plasma protein both in the plasma and the extravascular compartments. From the exponential nature of the decay curve predicted by this model, it is apparent that if the logarithm of the radioactivity in the plasma is plotted against time ( Fig. 5 ), there will be an initial relatively rapid fall in activity followed by linear decay. In contrast the extravascular activity will obviously start from zero and rise to a peak before decaying in parallel to the plasma activity. Conclusion 1. The decay of labelled plasma protein from plasma is determined by the rate 1. CURVE STRIPPING It is essential to obtain sufficient points on the straight line portion of the semi-log plot of the radioactivity of plasma (P) versus time to give a reliable straight line for the terminal exponen-
B. Application of a simple model
In practice the converse of this approach is required. That is, instead of commencing with rate constants and deriving the theoretical relationship between plasma radioactivity and time, we begin with the observed relationship between plasma radioactivity and time. The appropriate rate constants, i.e. the fractional catabolic rate k c and the rates of exchange between the extravascular compartment and the plasma (i.e. k l and k 2 ) have then to be derived. This requires taking a number of blood samples after intravenous injection of plasma protein labelled with radioactive iodide, with which we determine the radioactivity in the protein, and plotting these values against time. It is usually simpler to analyse the data when the results are corrected firstly for the decay of radioactivity of the isotope and secondly by 'normalising' , that is expressing the radioactivity in each sample as a fraction of the dose injected. The practical problem now is to determine the rate constants from the experimentally derived decay curve of radioactivity in the plasma. This requires as a first step the application of exponential curve stripping. Days tial portion of the decay curve ( Fig. 5 ). Linear regression can be applied. The gradient of this line gives the first exponent term b, and the intercept obtained by extrapolating the line to the y-axis gives the first intercept AI' We have now obtained one term of the equation i.e. Ale-b t ' . The next stage is to note the time corresponding to each of the data points of the initial rapidly decaying portion of the plasma curve. The corresponding values for each of these times is obtained by substituting in the expression Ale-b t ' . The values so obtained are then subtracted from the corresponding experimental points. These new difference values are then plotted again semi-logarithmically against the appropriate time to obtain a new decay curve. As before, a least-squares fit can be used to obtain the second intercept A z and the second gradient which gives the exponent term b z . This process can be achieved fairly rapidly with a small hand calculator provided it has exponential and logarithmic functions.
Obviously statistical functions are useful and the procedure can be readily programmed for any desk top, or microcomputer. Even if it is proposed to use a large computer to obtain a best fit to the data it is usually necessary to obtain preliminary estimates of the variables by the above procedure.
DETERMINATION OF RATES OF

CATABOLISM AND EXCHANGE
The rate constants can then be obtained from the following expressions (see appendix 2). Fractional catabolic rate:
The rate constants of exchange between compartments and the fractional catabolic rate can be determined in a straightforward fashion from the decay of the labelled plasma protein from plasma.
c. Reference 'normal' values for albumin in man
In many studies over the years the following values have been obtained for albumin in normal adult man. H • 9
(1) The fractional catabolic rate (k e ) is 0·1 per day (d). That is, 10% of the intravascular pool of albumin is broken down per day. Since the plasma volume of a 70 kg man is approximately 3 litres and we can take a 'rounded' albumin concentration as 40 giL, an estimate of the absolute catabolic rate of albumin, that is the total amount of albumin broken down per day, is given by 0·1 x 3 x 40 = 12 g per day. This assumes that the site of catabolism is the vascular compartment or, in kinetic terms, one very closely associated with it. While this is difficult to envisage, all the available evidence supports the validity of this assumption.
(2) The fractional rate of loss to the extravascular compartment (kd, usually conceived as 'capillary permeability' and measured directly as transcapillary escape rate (TER, see section F.8) is 1·2 per day. That is, 120% of the intravascular pool of albumin is lost to the extravascular pool each day.
(3) The fractional rate of lymphatic return (k z ) is approximately 0·9 per day, that is 90% of the extravascular pool of albumin is returned via the lymphatics to the vascular system each day.
(4) From the values of k, and k z we can obtain the ratio of the extravascular pool of protein (E) to the circulating protein (P), EIP [see equation (2) above]. This ratio is obtained fromk l/kz=1·210·9=1·33. Thus, there is approximately 30% more albumin in the extravascular 'space than there is circulating in the plasma. Alternatively, less than half the total body albumin is to be found circulating in the plasma in normal adult humans."
D. InOuence of extravascular plasma protein on the intravascular protein
The existence of this extravascular pool and its size has an important effect on the decay of radioactive labelled protein from the plasma. This is demonstrated in Fig. 6 .
In all of the decay curves shown, the fractional catabolic rate is the same, 0·1 d-I; that is, in each case 10% of the intravascular pool is catabolised per day. As is conventional in these representations of the decay of labelled plasma protein, the y-axis is the logarithm Of the radioactivity in the plasma expressed as a fraction of the amount of radioactivity injected. The figures were obtained by inserting the appropriate values in the simple computer model described below (section 1). .
NO EXTRAVASCULAR PROTEIN
In the first example, that is the single straight line (E=O), the fractional catabolic rate is 0·1 d-1 and there is no extravascular pool of protein.
Obviously in this case the decay is analogous to the decay of a single radioisotope, such as 131 1, 125 1, 32p etc. Note that the half-life of decay of the protein is 6·9 days.
NORMAL EXTRAVASCULAR PROTEIN
Consider now the fourth curve (the continuous line). This, as can be seen by comparison with Fig. 5 , shows the decay obtained in a normal individual. In this case the half-life of the terminal exponential is 16·4 days, despite the fact that the fractional catabolic rate of the albumin is still 10% per day. The EIP ratio is 1·3:1.
LOW el»
In obtaining curves 2 and 3, labelled EIP= 0·25:1, the extravascular to intravascular ratio of protein was set to 1:4. The curves were obtained, firstly by retaining the rate of loss from the plasma pool to the extravascular space (k 1 ) at the 'normal' value of 1·3 and setting the rate of return (k 2 ) from the extravascular pool to the plasma to four times its 'normal' value; secondly, k, was taken to be a quarter of its usual value and the lymphatic return (k 2 ) was returned to its 'normal' value. Note that the terminal exponential in each of these two curves is identical and is about 8·9 days, despite the fact that again the fractional catabolic rate is 0.1 d-1 .
VERY LARGE AMOUNT OF EXTRAVASCULAR PROTEIN
In the final two curves, labelled EIP=3:1, the extravascular space has been expanded by a factor of about 3. Again this is simply done in two ways, firstly by retaining k 1 constant and decreasing k 2 and secondly by increasing k, and retaining k 2 at its 'normal' value. Again note that the two curves give terminal exponentials which are almost identical, with a half-life of decay of approximately 29 days.
From these curves the quantitative significance of the extravascular pool of protein is apparent.
Conclusion 3. The half-life of the terminal exponential of the plasma-decay curve is significantly influenced by the proportion of the plasma protein in the extravascular space.
Conclusion 4. The half-life of the terminal exponential of the plasma-decay curve is not a measure of the fractional catabolic rate of the plasma protein.
E. Half-life of plasma protein
It must be noted that since half-life, tU2= {In 2)lk c , some confusion may arise from the common use of half-life to describe the slope of the terminal exponential of the decay of labelled plasma protein. It is not obvious in many publications whether the half-life of a plasma protein quoted is referring to the half-life of the terminal exponential or to that obtained by dividing In 2 (i.e. 0,693) by the correctly determined fractional catabolic rate of the protein. For this reason I believe the term 'half-life' should no longer be used when discussing plasma protein metabolism. The use of the term 'fractional catabolic rate' (FCR) would eliminate the possibility of confusion. F. Practical methods or determining the catabolic rate and distribution or albumin in man 1. COMPARTMENTAL ANALYSIS The first of 9J,ese methods is the compartmental analysis method described in section B above. It yields the rate constants of catabolism, of loss to the extravascular space and of return to the circulating blood. This method requires blood samples only.
It will be apparent from Fig. 5 that determining the catabolic rate and distribution of albumin from the decay of albumin labelled with radioactive iodide from plasma in man requires from about 15 to 20 or more days. Several blood samples are usually obtained in the first few days followed by daily blood samples from days 3 or 4 to the end of the study. In many patients, especially those not in a steady state for a period of 2 weeks, this method is quite impracticable. Thus, although we might regard the 'compartmental analysis' method described in sections A and B above as the 'reference method' for determining the catabolic rate and distribution of albumin in man, alternatives must be sought for practical application to patients. A list of methods available for calculating the results from plasma proteins labelled with radioactive iodide is given in Table 1 .
Compartmental analysis has also been applied to the decay of whole-body radioactivity determined directly in a whole body counter with not entirely satisfactory results.!? Consid-eration of the decay in excretion of inorganic 131I released from the radio-labelled protein by catabolism, which is discussed below in the description of the metabolic clearance method, does lead to satisfactory agreement between theory and observation.!! 2. METABOLIC CLEARANCE The so-called 'metabolic clearance' method ( Table 1 ) of determining the catabolic rate of a radio-iodinated plasma protein has been widely used. The basis for this is that we can write from the simple model of Fig. 4 , dUldt=kcPso that the fractional catabolic rate, k c=(dUldt)(IIP}. Since a 24-hour urine collection can be taken as a particular estimate of dUldt, we can divide it by the radioactivity of the protein in plasma at about the mid-point of the urine collection period to obtain an estimate of the fractional catabolic rate of the protein.
It is important however to consider the effect of delay in iodide excretion when applying this 'metabolic clearance' method because it can give rise to errors.F In the case of albumin the error is significant only for the first few days after injection of the radioactive protein. From about the fifth or seventh day onwards in a normal individual, results are usually obtained which are very close to those obtained by the compartmental analysis method. The theoretical basis of this error is given in appendix 3.
RECOVERY OF RADIOACTIVE IODIDE IN
URINE
There is another source of error in methods requiring an estimation of the amount of radioactive iodide excreted in the urine. In addition to the problem of ensuring complete urine collections, it has been recognised for some time that the recovery of radioactive inorganic iodide in the urine may be as low as 80%. It has never been observed to be greater than 95%. 13 With colleagues in Glasgow these observations have been confirmed by careful studies in volunteers. In all studies requiring quantitative measurement of radioactive iodide excreted in the urine, it is essential to determine the 'recovery' of such iodide. In normal individuals the plateau of recovery is obtained between 3 to 5 days after intravenous injection of radioactive inorganic iodide.
The remaining methods listed in Table 1 seem not to have been widely used in humans.
'EQUILIBRIUM TIME' METHOD
In the equilibrium time method;" the equilibrium referred to is in the exchange of labelled protein between the extravascular and intravascular pools. The equilibrium occurs at the peak of the curve of activity of labelled protein in the extravascular space i.e. when dEldt=O. From equation (2), at this time k 1P=k2E. If we use this result in equation (1) above we also see that at equilibrium time dPldt=-keP, from which the fractional catabolic rate (k e ) can be calculated. When applying this method to the study of albumin in humans, a broad peak is obtained for the radioactive protein in E and it is essential to obtain many blood samples to ensure reliable exponential curve fitting to the data.
NOSSLIN'S INTEGRAL METHOD
In my experience, of the two methods proposed by Nosslin'P in the studies of albumin metabolism, only the integral method is satisfactory. Results can be obtained in a study period of 5 to 7 days. In essence, the calculations are based on simple rearrangements of equations 1 and 2 followed by integration.
DECONVOLUTION
Deconvolution methods have been discussed by Wraight. 16 They do not seem to offer any advantage over Nosslin's integral method, 7 . CONVOLUTION The convolution method proposed by Bianchi et al. 17 would seem to offer the most useful reduction in the time required for the study of albumin metabolism in man. Our as yet unpublished studies have demonstrated good agreement among the convolution method, cornpart-mental analysis and the direct determination of albumin synthesis rate by a modification of McFarlane's method;" in both normal individuals and patients suffering from cancer. The convolution method requires:
(a) Intravenous injection of a relatively large dose IlCi) of 13I1-labelled albumin, together with a small dose (20 IlCi) of Na 125 I. Obviously, as in all studies with iodine-labelled proteins, the prior and continuing administration of Kl is essential to prevent uptake by the thyroid.
(b) Frequent blood samples. A minimum of 20 samples in 24 hours is required to give good exponential curve fitting to both the decay of labelled protein (P) and of labelled iodide ( 125 1). Apart from a few samples of about 20 mL required to determine the activity of free 131 1 in the plasma (i.e. that released from the albumin by catabolism), each blood sample need only be about 3 mL.
The fractional catabolic rate k e is given by k e = 13Iu(p* 125 1) .
Note that the asterisk (P*) represents the operation of convolution (see appendix 4) which can be programmed readily for a microcomputer.
LOSSTOTHEEXTRAVASCULARSPACE
There is a simple method for obtaining a good approximation of the rate of albumin loss from the blood to the tissue spaces. This is known as the transcapillary escape rate (TER) and is determined by the injection of labelled albumin and measuring the rate of disappearance from the plasma during the first hour after intravenous injection.l? The 'normal' value is 5% per hour. The basis of this determination is given in equation 1 above. During the first hour after intravenous injection of labelled protein it can be assumed that the amount of labelled albumin returning to the plasma from the extravascular space is negligible, thus putting k 2E=0 in equation (1), giving dPldt= (-k 1+kc)P. At time zero, P=l, so that the gradient dPldt=(-k 1+kc ) ' In addition, since k c is approximately 0·1 d-1 , whereas k, is approximately 1·2 d-\ the error in ignoring k c and taking the gradient (dPldt) as giving the transcapillary escape rate is negligible.
G. Measurement of rate of synthesis
The determination of the synthesis rate of Plasma voI.=3 L; plasma albumin concentration= 40 gIL; so that P=total amount of albumin circulating in the blood vessels= 120 g. changes in rate constants. The solution was obtained in the same way as is outlined in appendix 1 for the simple two-compartment model for the metabolism and distribution of plasma protein labelled with radioactive iodide.
THE EFFECTS AND CHANGES IN RATES
OF SYNTHESIS AND BREAKDOWN
It was found that this permitted solutions for each plasma protein concentration to be obtained at intervals of 0·1 day rather than the very much shorter intervals of 0·001 day which were necessary if a purely numerical solution were adopted. The analytical approach therefore considerably reduces the number of calculations and hence the computing time. This renders it practicable for small desk-top or microcomputers, whereas a purely numerical approach, that is of direct solution of the differential equations, requires considerably more computing memory and power. At present, the model is written in FORTRAN albumin in vivo requires an entirely different approach. Because urea is synthesised from CO 2 and NH 3 in the liver initially as part of the arginine molecule, which is also available for incorporation into proteins synthesised in the liver, intravenous injection of Na214C03 leads to 14C appearing in both urea and plasma proteins. If the synthesis rate of urea can be determined, the synthesis rate of the plasma protein can be calculated from the ratio of the specific activity of the 14C in urea to that in the guanidino-carbon in arginine in the protein. In practice, correction has to be made for losses of 14C-labelled protein by catabolism and to the extravascular space. This is achieved by injecting 13l1-labelled protein with the Na214C03' For patients, the most appropriate method of determining the synthesis rate of urea is to inject intravenously 13C-labelled urea (together with the labelled carbonate and protein), follow its disappearance from plasma, and assume that in the short 12-hour period of the study this decay rate equals the synthesis rate of urea. This method has been applied to determine the synthesis rate of albumin.P and more rarely fibnnogen," in man.
H. Other relevant measurements
It is evident from the above discussion that methods exist for the determination of the fractional catabolic rate of a plasma protein, its rate of loss to the extravascular space, and its rate of synthesis. Additional measurements relevant to any discussion of the metabolism and distribution of a plasma protein are: its concentration in plasma; the plasma volume; abnormal losses in the urine, from the gut, or by haemorrhage. The body weight, blood volume, and finally body water are also relevant, although the last two are rarely measured during studies of plasma protein metabolism.
I. Computer model for determining causes of changes in concentration of a plasma protein
We can now go on to consider with the aid of a simple computer model the relative importance of the factors mentioned above in determining the concentration of a protein in plasma. The basis of the model is summarised in Fig. 7 , which also indicates the assumed 'normal' values for each of the rate constants. In order to be able to use a small computer an analytical approach was adopted to solving for the changes in concentration produced by .~35
.a <t tion so that as the concentration of albumin falls the fractional synthesis rate increases.P The latter implies that the absolute synthesis rate of albumin may be independent of its concentration. The model has been written to include these relationships and also the observation that the capillary permeability (k 1 ) is directly . f lb . 27 proportional to the concentration 0 a urmn . The effects of changes in 'capillary permeability' and in lymphatic return are shown in Fig. 9 . The changes in concentration of albumin were produced by changes of 30% in the rate constants--an increase of 30% in capillary permeability and a decrease of 30% in lymphatic return. Again as expected, the consequences of these changes are very similar; a rapid fall in albumin concentration followed by a slow recovery. It should be noted that the fall in albumin concentration is very much more rapid following changes in vascular permeability than when the same proportional change is applied to fractional rates of synthesis or to catabolism. Because of the compensatory changes in the fractional rates of synthesis and catabolism after a fall in albumin concentration, the changes in concentration following changes in 'capillary permeability' or lymphatic return are transient.
CHANGE IN PLASMA VOLUME,
INCLUDING HAEMORRHAGE
As expected, a sudden change in plasma volume, in this case an increase of 30%, synthesis. As expected the change in concentration of plasma albumin is exactly the same after an increase of 30% in the fractional catabolic rate as when the fractional synthesis rate is decreased by 30%. The slow rate of fall in concentration of albumin in the plasma is noteworthy following this sharp and considerable change in the fractional catabolic rate of synthesis or catabolism. Extending the calculation revealed that a period of about 80 days was necessary in order to obtain the new equilibrium of albumin concentration of 30 g per litre following this 30% fall in synthesis rate or 30% increase in catabolic rate. Circumstances occurring in vivo which influence the rates of synthesis and catabolism of albumin are not entirely known or understood. For example, it is clear from the data of Keys et ai. 22 that although there was a fall of 7% in the concentration of albumin following 24 weeks of reduced protein and energy intake in man, during which the body weight fell by 25%, the plasma volume increased somewhat during this time so that the final total amount of circulating albumin was almost unchanged. In contrast, when experimental animals have been fed adequate energy but very low or no protein, albumin concentration has been found to fall significantly within a few days. 23 The administration of hydrocortisone to man has been shown to increase the rate of catabolism of albumin.j" Finally, there is experimental evidence to indicate that the fractional catabolic rate of albumin is directly proportional to albumin concentration, so that as concentration increases the catabolic rate also increases.P In contrast, the fractional synthesis rate of albumin is inversely proportional to its concentra- 
RELATIVE SIGNIFICANCE OF THE
FACTORS INFLUENCING ALBUMIN
CONCENTRATION
It is clear from Figs 8 to 11 that the factors listed above, which may influence the concentration of albumin in plasma, have been given in order of the magnitude of their effect and the speed of response. A preliminary attempt at assessi~g the relative magnitude of these factors 1S illustrated in Table 2 . This emphasises the acute effect of changes in fluid volume, the relatively "rapid effects of changes in capillary permeability and lymphatic return, and .shows t~e relative unimportance for producing rapid changes in the concentration of albumin ip lasma, of modification of the rates of synthesis or catabolism.
J. Factors influencing albumin concentration in patients
Having reviewed the physiological background to the factors determining the concentration of plasma albumin in man, we can now summarise the factors which may influence the concentration in disease. 45 Fig. 11 the effects of direct losses from the plasma compartment and of intravenous infusion to the plasma compartment are shown. As anticipated, direct loss of protein from the vascular space produces a gradual fall in the concentration of albumin. Depending on the magnitude of the losses a new equilibrium will eventually be obtained with a final low concentration of albumin.
LOSSES AND INFUSION OF PROTEIN Finally, in
When albumin is infused intravenously (Fig.  11) there is a sharp but transient rise in albumin concentration followed by an equally sharp fall to a level only slightly greater than the starting concentration. This is mainly related to the loss to the extravascular compartment of more than half the infused albumin in a day. This result is consistent with clinical experience. Intravenous infusions of albumin or plasma always have a disappointingly small effect on increasing albumin concentration. 29 50 produces a very rapid fall in albumin concentration ( Fig. 10) . Again, there is a compensatory recovery due to the inflow of protein from the extravascular space and also due to increases in synthesis and a decrease, at least initially, in catabolism. The changes induced by haemorrhage were modelled on the data of Skillman et al. 28 but in summary are similar to those produced by a change in plasma volume. In the case of haemorrhage several mechanisms appear to operate. Firstly, there is some recovery of plasma water, followed by inflow of protein from the extravascular space, then~y an increase in synthesis and a decrease in catabolism; all lead to gradual recovery of protein concentration. . FeR represents the fraction of the intravascular pool of protein catabolised per day (k c ) ' II=iodide pool into which intravenously injected iodide is rapidly distributed (it corresponds approximately to the volume of the extracellular fluid). I 2=iodide pool which exchanges with II' The fractional rates of exchange of iodide between pools 11 and 1 2 are denoted by k 4 and k 5 in the text. Excretion indicates that radioactive iodide released from the radio-iodine-labelled protein is excreted in the urine. This fractional rate of excretion is represented in the equations in the text by k c . I represents the iodide released from protein to be excreted in the urine (U). Note: In the case of albumin a 3-exponential curve for the decay of radio-iodinated albumin from plasma has been commonly described." This implies three compartments, i.e. plasma and two extravascular pools. The physiological significance of the second extravascular pool is not clear and it has been 'lumped' with the main pool in this discussion.
(1) Posture. Albumin concentration is greater in subjects standing upright than in recumbent individuals, and will therefore be greater when the same individual is an out-patient than when an in-patient.
(2) Body fluid volume and distribution.
(3) Starvation. Acute starvation leads to an increase in concentration in albumin during the first 3 days.22, 30 (4) Protein energy depletion. Proportional decreases in the intake of energy and protein lead to little change in albumin concentration. 22 (5) Severe protein depletion with either adequate energy or less marked inadequacy of energy intake leads to a fall in albumin concentration.P: 31 (6) Injury, including infection. Albumin concentration falls after trauma.P is low during infections.P and bums often lead to a marked fall in albumin concentration.P" (7) Disease associated with direct loss of albumin from the body. These include proteinlosing enteropathy'? and nephrosis.r" (8) Cancer, especially advanced or with multiple secondaries is often associated with low albumin concentration. 37 (9) Chronic disease. Sufferers from rheumatoid arthritis often have low albumin concentration. 38 (10) Chronic liver disease. This is commonly assumed to be a cause of low albumin concentration. 39 In many of the examples of diseases given above, an increase in the catabolic rate of albumin has been shown; examples include injury,40 bums,34 rheumatoid arthritis'" and cancer.t' However, it is clear when we consider the relative importance of these factors in determining albumin concentration that the changes in the synthesis and in the catabolic rates of the protein are unlikely to be the sole cause of the low albumin concentration observed in these conditions. After injury, albumin concentration falls rapidly, especially in moderately severe injury, but also in myocardial infarction, reaching a minimum in about 2 to 5 days.32 This rapid fall cannot possibly be explained by changes in the rates of synthesis and catabolism alone. By applying the simple computer model it can be shown that synthesis would have to be completely inhibited and catabolism increased by a factor of at least two to achieve the same rate of fall in albumin concentration. 42 In chronic liver disease direct measurements of albumin synthesis rates in vivo have demonstrated that in some cases it is increased." From the discussion in section 1.1 above this should not be surprising. Liver disease is commonly associated with fluid retention and increased fluid volume.j" The consequent reduced albumin concentration would stimulate an increase in the rate of albumin synthesis which has been observed.P A complication may be the association of alcoholism with inadequate protein intake and less severe reduction of energy intake.r' However, only when liver damage is very extensive is it likely that the primary cause of the subnormal concentration of albumin is destruction of hepatocytes.
Important factors producing early changes in albumin concentration in disease are likely to be vascular permeability and lymphatic return. There is evidence of a general systemic increase in vascular permeability following burning injury45 and in diabetes mellitus.t"
Conclusions
(1) In disease there are likely to be changes in fluid balance, in capillary permeability and in lymphatic return due to recumbency and reduced muscle activity, all of which tend to decrease the concentration of albumin. There may be direct losses of albumin from the gut or urine or in haemorrhage, and there may be both increased catabolism and decreased synthesis. In almost all cases these factors will operate together, tending to decrease the concentration of albumin in plasma. Thus the more severe the disease process the lower the plasma albumin concentration is likely to be.
(2) Changes in nutrition alone may lead to an increase in albumin concentration (acute starvation); little change in albumin concentration (prolonged combined protein and energy depletion); or a gradual fall in aibumin concentration (severe protein depletion when some energy is available). Changes in albumin concentration induced by changes in the intake of nutrients are likely to be slow in effect, as has been demonstrated by the computer model (section I), and should be evident from the fact that less than 5% of the total body albumin is catabolised and re-synthesised each day.
(3) In disease associated with a decrease in albumin concentration, it is possible that albumin synthesis is increased, not decreased, at least in the early stages. Examples include protein-losing enteropathy, nephrosis and chronic liver disease. There is clear evidence that the low albumin concentration found in chronic liver disease may be due to the dilution effect of increased fluid retention rather than impaired synthesis of albumin. In addition, the control mechanism influencing albumin synthesis rate is such that a low concentration of albumin leads to an increase in the synthesis rate.
Sufficient evidence has now been presented to draw three important conclusions about plasma albumin concentration in man:
(1) it may be a useful prognostic indicator in disease;
(2) it is not a satisfactory general indicator of nutritional status;
(3) it is not a direct liver function test.
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Rearrangement gives:
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from which the solutions for p and e can be written directly as The denominator can be rearranged to form the quadratic s2+(k,+k 2+kc)s+k2kc , which can be written (s+bd(s+b 2 ) , where b, and b 2 corres-.pond to the roots of the quadratic in s.
It is useful to note that by equating coefficients,
(2)
Appendix 1. The deay of radio-labeUed protein from plasma after its intravenous injection and the behaviour of extravascular labeUed protein
An expression for decay of radio-labelled plasma protein from the plasma after injecting it intravenously can be obtained by solving the differential equations given in the text, viz., where P is the amount of radio-labelled protein in the plasma and E is the amount of the labelled protein in the extravascular space. Of the several possible approaches, the simplest is to use matrices and Laplace transforms, as used by Resigno'" and Matthews. 4 The symbols k lo k 2 and k c represent the fractional rates: k, of loss from the plasma pool to the extravascular pool (k cp in conventional terminology' 3); k 2 of return from the extravascular pool to the plasma pool (kpe by conventionv '), and k c of catabolism.
The first step is to take the Laplace transforms of equations 1 and 2. The process of Laplace transformation is defined by:
The Laplace transforms can be inverted directly using Churchill's theorem 12,48 which is: (9) (11) (10) we can now rewrite equations (5) and (6), noting that the denominators are the same:
in which e-st is chosen such that 1(.) converges to a finite value, thus permitting simple conventional algebraic manipulation.t" The Laplace transform of the differential operation is given
is the value of the function F(I) at 0 time. In the case of P(t) at 0 time, i.e. immediately after intravenous injection, its value is 1. In the case of E(I)' obviously the value at 0 time is O. Laplace transformation applied to equations (1) and (2) gives:
in which the quotient q~is obtained by dividing pes) by all the factors of q(s) except s-a, (14) It is common to write these equations in the form: (21) co It is obvious that k c = 1/f p(t) dt, that is, that o the fractional catabolic rate is given by the dose of injected label divided by the area under the decay curve, a process which is familiar to those calculating cardiac output from dye decay curves. 3 The final solution is for k, which is obtained by difference. From equation (18), k i = b l+b2 -k 2-kc • Inserting the result of equation (19) and noting that Al = l-A 2 and rearranging gives which is often written in the form (12) 
to obtain
It can be readily seen by substitution that Al +A 2=1, which is consistent with the value of P at time 0, which is the total injected dose of radioactive protein, taken as 1·0. Similarly, since eO=I, the value of E at time 0 is 0, which is again consistent with the initial assumptions.
It is apparent that all the rate constants (i.e. kr. k 2 and k c ) , can be obtained from the experimentally determined values of the intercepts (AI and A 2 ) and exponents (b l and b 2 ) of the equation for the decay of radio-labelled protein in the plasma, i.e.
Equating coefficients and noting that at t=O, P=1 and E=O, we see by combining equations (16) and (1) 
Appendix 3. Error in metabolic clearance method. Determination of fractional catabolic rate Taking U to represent the cumulative excretion of radioactivity in urine, dUldt is the rate of excretion of breakdown products in the urine and could be, for example, the radioactivity excreted in 24 hours, and P the activity of the radio-iodinated protein in the plasma at the mid-time of the urine collection, the simple two-compartment model ( Fig. 4) gives
From equation (9), by rearrangement,
so that after substituting the result of equation (17), and noting that A I+A 2=1, we find However, omitting consideration of redistribution and excretion of iodide is an oversimplification so that the error in using the expression k c = (dUldt)(I/P) must be determined. From the compartmental model which includes iodide pools II and 1 2 (see Fig. 12 ) we can write From equation (8), k 2 = b 1b 2/kc ' Inserting this result in equation (18) gives (19) (20) dh/dt = k 4II-k sI2
If we now combine equations (26) and (27) we obtain: (31) which has been used by Wraight 16 in studies of plasma protein metabolism.
The convenient experimentally obtained data in studies of plasma protein metabolism following the intravenous injection of a plasma protein labelled with radioactive iodide are: The operation of convolution is commutative, distributive and associative under conditions which apply in the consideration of plasma protein metabolism.
Also, given the input and output functions, the transfer function can be obtained by deconvolution, i.e.
which rearranges to k e = (dUldHd/ 1/dt) (liP).
After 1 or 2 hours an approximate 'equilibrium' or steady-state of radioactive iodide can be assumed, so that errors in assuming 1 2 = kJl/ks will be small [from equation (25) ].
We can insert this result into equation (24) , observe that the terms in k 4 / 1 cancel, to obtain: From this result it is apparent that the 'metabolic clearance' method of determining FeR (=k e ) is in error by the term (d/ 1/dt) (liP).
It seems obvious that dl-fdt will rise rapidly after injection of the labelled protein as will the value of k e , a maximum will be attained, after which there will be a gradual approach to zero. Thus it is likely that error persists in the metabolic clearance method throughout a study.
It is tempting to speculate that the closeness of agreement of the metabolic clearance and compartmental analysis methods is due to incomplete recovery of iodide in the urine.
in which * represents the convolution opera-in which B(.) is the output function, and A(r) the input function.
Equation (29) in which t is a small time interval was recognised by Stephenson'? as the convolution integral.3, 48 The convolution of A(.) with the transfer, or weighting function G(t) can be written as
Appendix 4. Convolution
The theory of transport in linear biolo §ical systems has been explored by Stephenson." He showed that if a linear relation could be assumed, the exchange between two compartments was described, in modern nomenclature, by the expression U(.), the cumulative excretion of radioactivity in the urine; and W(.) , whole body radioactivity. Also since n E(.) =! e,exp (-bit 
can be derived by difference from measurements of Wor U and P, and iodide metabolism can also be described by a series of exponential functions, the application of convolution or deconvolution operations to plasma protein metabolism should be straightforward.
CONVOLUTION OF P WITH II
In order to distinguish the decay curve of intravenously injected radioactive inorganic iodide in the plasma from inorganic iodide released from the iodine labelled protein, the latter will be referred to as 131 1 and the former as 12SI. the decay of plasma protein radioactivity with time; If we consider the excretion and distribution of 131 1 as occurring in discrete steps in small time intervals (tr), then the iodide released in tlo is kePI and in t2, k eP2 , and so on. If we assume in addition that the inorganic iodide released in t1 will be distributed and excreted in the same way as intravenously injected inorganic iodide, each 'discrete' amount of 1311 released by metabolism of the iodinated protein will decay exponentially from the first iodide pool:
The same will apply to the iodide released in the interval tz etc.
Since P is a function of time, 13111 changes with time, and is the sum of the series of the products of keP(,), which can be written as the convolution integral Stephenson.f? Cuenod and Durling'" and Shipley and Clark.?
In this example, 125 1 1 is the transfer or weighting function in the convolution k eP.
125
[ 1 = 131 1 1 which on rearrangement gives k e = 13111/(P. 125ld· (32) It follows from this equation that if, say, a plasma protein labelled with 131 1 is injected intravenously together with Na 125 l , and the curves of decay of radioactivity with time are plotted to yield the appropriate exponential functions for P and [1, and the 1311 inorganic iodide in the plasma (13111) also determined, then the FCR (k e ) can be determined by using the convolution result P. 125 I. This is the method of determining FCR introduced by Bianchi et at. 17 for the determination of the FCR of albumin in patients within the relatively short period of 24 hours. It is the analytical expression of the intuitive concept that after the injection of an iodinated plasma protein, if we can measure the radioactive protein in the plasma and the amount of radioactive iodide released from the protein by metabolism, we should be able to calculate the catabolic rate of the protein.
